150 related articles for article (PubMed ID: 16267835)
1. Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts.
Kahler RA; Galindo M; Lian J; Stein GS; van Wijnen AJ; Westendorf JJ
J Cell Biochem; 2006 Apr; 97(5):969-83. PubMed ID: 16267835
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancer-binding factor 1 (Lef1) in proliferating osteoblasts.
Galindo M; Kahler RA; Teplyuk NM; Stein JL; Lian JB; Stein GS; Westendorf JJ; van Wijnen AJ
J Mol Histol; 2007 Oct; 38(5):501-6. PubMed ID: 17885813
[TBL] [Abstract][Full Text] [Related]
3. Microtubule actin crosslinking factor 1 promotes osteoblast differentiation by promoting β-catenin/TCF1/Runx2 signaling axis.
Hu L; Su P; Yin C; Zhang Y; Li R; Yan K; Chen Z; Li D; Zhang G; Wang L; Miao Z; Qian A; Xian CJ
J Cell Physiol; 2018 Feb; 233(2):1574-1584. PubMed ID: 28621459
[TBL] [Abstract][Full Text] [Related]
4. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
5. Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation.
Hoeppner LH; Secreto F; Jensen ED; Li X; Kahler RA; Westendorf JJ
J Cell Physiol; 2009 Nov; 221(2):480-9. PubMed ID: 19650108
[TBL] [Abstract][Full Text] [Related]
6. Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1 (Lef1) and negatively regulates osteoblast maturation.
Kahler RA; Yingst SM; Hoeppner LH; Jensen ED; Krawczak D; Oxford JT; Westendorf JJ
Matrix Biol; 2008 May; 27(4):330-8. PubMed ID: 18280717
[TBL] [Abstract][Full Text] [Related]
7. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
8. Mineralization initiation of MC3T3-E1 preosteoblast is suppressed under simulated microgravity condition.
Hu LF; Li JB; Qian AR; Wang F; Shang P
Cell Biol Int; 2015 Apr; 39(4):364-72. PubMed ID: 25318973
[TBL] [Abstract][Full Text] [Related]
9. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter.
Kahler RA; Westendorf JJ
J Biol Chem; 2003 Apr; 278(14):11937-44. PubMed ID: 12551949
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte enhancer-binding factor 1: an essential factor in odontoblastic differentiation of dental pulp cells enzymatically isolated from rat incisors.
Yokose S; Naka T
J Bone Miner Metab; 2010 Nov; 28(6):650-8. PubMed ID: 20425127
[TBL] [Abstract][Full Text] [Related]
11. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid disrupts osteogenesis in pre-osteoblasts by down-regulating WNT signaling.
Roa LA; Bloemen M; Carels CEL; Wagener FADTG; Von den Hoff JW
Int J Biochem Cell Biol; 2019 Nov; 116():105597. PubMed ID: 31479736
[TBL] [Abstract][Full Text] [Related]
13. Interaction of LEF1 with TAZ is necessary for the osteoblastogenic activity of Wnt3a.
Kida J; Hata K; Nakamura E; Yagi H; Takahata Y; Murakami T; Maeda Y; Nishimura R
Sci Rep; 2018 Jul; 8(1):10375. PubMed ID: 29991769
[TBL] [Abstract][Full Text] [Related]
14. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development.
Quarles LD; Yohay DA; Lever LW; Caton R; Wenstrup RJ
J Bone Miner Res; 1992 Jun; 7(6):683-92. PubMed ID: 1414487
[TBL] [Abstract][Full Text] [Related]
15. Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass.
Hoeppner LH; Secreto FJ; Razidlo DF; Whitney TJ; Westendorf JJ
J Biol Chem; 2011 Apr; 286(13):10950-9. PubMed ID: 21270130
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
17. Osteoblast differentiation is functionally associated with decreased AMP kinase activity.
Kasai T; Bandow K; Suzuki H; Chiba N; Kakimoto K; Ohnishi T; Kawamoto S; Nagaoka E; Matsuguchi T
J Cell Physiol; 2009 Dec; 221(3):740-9. PubMed ID: 19725053
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-2 regulates matrix mineralization in MC3T3-E1 pre-osteoblasts.
Alford AI; Terkhorn SP; Reddy AB; Hankenson KD
Bone; 2010 Feb; 46(2):464-71. PubMed ID: 19744582
[TBL] [Abstract][Full Text] [Related]
19. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer.
Leclerc N; Noh T; Khokhar A; Smith E; Frenkel B
Arthritis Rheum; 2005 Mar; 52(3):929-39. PubMed ID: 15751078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
